Celltrion
068270.KS
#891
Rank
โ‚น2.669 T
Marketcap
โ‚น11,640
Share price
-0.73%
Change (1 day)
4.91%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Revenue for Celltrion (068270.KS)

Revenue in 2026 (TTM): โ‚น280.50 Billion

According to Celltrion 's latest financial reports the company's current revenue (TTM ) is โ‚น300.27 Billion. In 2025 the company made a revenue of โ‚น264.22 Billion an increase over the revenue in the year 2024 that were of โ‚น221.06 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Celltrion from 2008 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น280.50 B6.16%
2025 โ‚น264.22 B19.52%
2024 โ‚น221.06 B61.02%
2023 โ‚น137.29 B-5.42%
2022 โ‚น145.15 B18.21%
2021 โ‚น122.79 B5.28%
2020 โ‚น116.63 B68.51%
2019 โ‚น69.21 B10.86%
2018 โ‚น62.43 B14.86%
2017 โ‚น54.35 B37.51%
2016 โ‚น39.52 B13.33%
2015 โ‚น34.87 B22.32%
2014 โ‚น28.51 B122.81%
2013 โ‚น12.79 B-27.22%
2012 โ‚น17.58 B
2010 โ‚น7.04 B29.64%
2009 โ‚น5.43 B55.34%
2008 โ‚น3.49 B